Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus

NCT00626717 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital Freiburg

Collaborators